Total Returns (Price + Dividend) 
Chandra Bhagat for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News
Announcements 
Board Meeting Outcome for Outcome Of Board Meeting Held On 13Th November 2026
13-Nov-2026 | Source : BSEOutcome of the Board Meeting held on 13th November 2026 for approval of un-audited result as on 30th September 2026.
Financial Result As On 30Th September 2026.
13-Nov-2026 | Source : BSEOutcome of the Board Meeting held on 13th November 2026.
Board Meeting Intimation for Approval Of Un-Audited Results As On 30Th September 2026.
07-Nov-2026 | Source : BSEChandra Bhagat Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 inter alia to consider and approve Un-audited Result for half year ended 30th September 2026.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Hemant Chandravadan Bhagat (35.5%)
Team Anamika Algo Limited (5.77%)
12.58%
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 17.20% vs -66.42% in Mar 2025
Growth in half year ended Sep 2025 is 164.71% vs -75.00% in Mar 2025
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -60.83% vs 84.98% in Mar 2024
YoY Growth in year ended Mar 2025 is -43.79% vs 68.13% in Mar 2024